PLMA_1170x120_10-8-21

September 20, 2021

Coming soon to a pharmacy near you: Biosimilars

Coming soon to a pharmacy near you: Biosimilars

Working at the forefront of health care, pharmacists have seen myriad transformations of the prescription medicines landscape. And they are about to see another new development: biosimilars dispensed at the pharmacy. The expanded availability of biosimilars will also change the role of pharmacists, increasing their ability to help patients access more-affordable treatments. Currently, biologic therapies

Fulfilling interchangeables’ promise will take work

Fulfilling interchangeables’ promise will take work

Pharmacy-substitutable biologics, known as interchangeables, have long been little more than an idea. Since the Biologics Price Competition and Innovation Act of 2009 (BPCIA) created a dual pathway for follow-on biologics — with biosimilars that are prescribed by name by a health care provider and interchangeables that can be automatically substituted at the pharmacy —

Here’s how to retain consumers gained during COVID

Here’s how to retain consumers gained during COVID

One of the most positive stories to come out of the pandemic is the pivotal role that retail pharmacies played in the vaccination effort and how it helped the country gain control over the spread of COVID 19. While chain drug had already contributed to the response effort before the vaccinations with COVID-19 testing, drug

Video Forum: Wendy Liebmann, WSL Strategic Retail

Video Forum: Wendy Liebmann, WSL Strategic Retail

Wendy Liebmann has devoted her career to charting the changing wants and needs of consumers and analyzing what that evolution means for the retail and CPG sectors. In this week’s Video Forum, Liebmann, chief executive officer and chief shopper at WSL Strategic Retail, talks about mass market retailers’ performance during the COVID pandemic, ongoing industrywide

Changes to Medicare Part D threaten savings for seniors

Changes to Medicare Part D threaten savings for seniors

On the tiering issue for generics, answering the question: “Why are your Part D patients paying higher co-pays for low-cost generics?” The availability of generic drugs has long meant safe, effective and affordable access to medicines for America’s patients. Generics are an integral component of patient care, offering quality, lower-cost versions of prescription drugs approved

How the country’s reopening affects consumer behavior

How the country’s reopening affects consumer behavior

The sudden onset of a global pandemic radically changed consumer behavior. Now brands and retailers are wondering how the country’s reopening will affect and change consumer sentiment. While the COVID-19 crisis isn’t over, many Americans are vaccinated, and states across the country have eased social distancing regulations. People are resuming activities that were off limits